Author： Parkinson Craig Trainer Peter J
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.9, 2001-09, pp. : 1725-1735
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pegvisomant shows potential in the treatment of acromegaly
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :
Access to resources
Recommend
Pegvisomant modulates cortisol metabolism in acromegaly
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
Long-term pegvisomant therapy promising in acromegaly
Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. :
Pegvisomant normalises markers of bone turnover in acromegaly
Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. :
Guidelines for the management of acromegaly
Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. :